ODDB.org: Open Drug Database

GlaxoSmithKline AG - Incruse Ellipta, einzeldosiertes Pulver zur Inhalation

Swissmedic Registration	65091	Sequence	01
Product name	Incruse Ellipta	Description	einzeldosiertes Pulver zur Inhalation
ATC-Classification	Codice	ATC-Description
Introduction of Sequence	29.09.2014

Composition

umeclidinium 62.5 µg ut umeclidinii bromidum, magnesii stearas, lactosum monohydricum, ad pulverem pro dosi, umeclidinium 55 µg pro dosi, doses pro vase 30.

Packungsbestandteile

Galenic Form

Inhalation Powder

Excipiens

Active Agent	Dose
Umeclidinium	62.5 µg

BAG: Active Agent	Dose
Umeclidinium	55 mcg

Inactive agents
Lactose Monohydrate
Magnesii Stearas

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001	30 unidose(s)	34.64	54.10	B	SL	Yes
002	3 x 30 unidose(s)	103.00	128.45	B	SL	Yes

2025	©ywesee GmbH